SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001564590-22-026717
Filing Date
2022-07-27
Accepted
2022-07-27 17:11:01
Documents
59
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q vktx-10q_20220630.htm   iXBRL 10-Q 2705296
2 EX-31.1 vktx-ex311_8.htm EX-31.1 20481
3 EX-31.2 vktx-ex312_7.htm EX-31.2 20459
4 EX-32.1 vktx-ex321_6.htm EX-32.1 12578
  Complete submission text file 0001564590-22-026717.txt   9226804

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA vktx-20220630.xsd EX-101.SCH 54268
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE vktx-20220630_cal.xml EX-101.CAL 42244
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE vktx-20220630_def.xml EX-101.DEF 185634
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE vktx-20220630_lab.xml EX-101.LAB 418492
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vktx-20220630_pre.xml EX-101.PRE 336666
53 EXTRACTED XBRL INSTANCE DOCUMENT vktx-10q_20220630_htm.xml XML 1771034
Mailing Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121
Business Address 9920 PACIFIC HEIGHTS BLVD, SUITE 350 SAN DIEGO CA 92121 858-704-4660
Viking Therapeutics, Inc. (Filer) CIK: 0001607678 (see all company filings)

IRS No.: 461073877 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37355 | Film No.: 221111790
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences